Literature DB >> 17553421

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

Eric M Reiman1, Jennifer A Webster, Amanda J Myers, John Hardy, Travis Dunckley, Victoria L Zismann, Keta D Joshipura, John V Pearson, Diane Hu-Lince, Matthew J Huentelman, David W Craig, Keith D Coon, Winnie S Liang, RiLee H Herbert, Thomas Beach, Kristen C Rohrer, Alice S Zhao, Doris Leung, Leslie Bryden, Lauren Marlowe, Mona Kaleem, Diego Mastroeni, Andrew Grover, Christopher B Heward, Rivka Ravid, Joseph Rogers, Michael L Hutton, Stacey Melquist, Ron C Petersen, Gene E Alexander, Richard J Caselli, Walter Kukull, Andreas Papassotiropoulos, Dietrich A Stephan.   

Abstract

The apolipoprotein E (APOE) epsilon4 allele is the best established genetic risk factor for late-onset Alzheimer's disease (LOAD). We conducted genome-wide surveys of 502,627 single-nucleotide polymorphisms (SNPs) to characterize and confirm other LOAD susceptibility genes. In epsilon4 carriers from neuropathologically verified discovery, neuropathologically verified replication, and clinically characterized replication cohorts of 1411 cases and controls, LOAD was associated with six SNPs from the GRB-associated binding protein 2 (GAB2) gene and a common haplotype encompassing the entire GAB2 gene. SNP rs2373115 (p = 9 x 10(-11)) was associated with an odds ratio of 4.06 (confidence interval 2.81-14.69), which interacts with APOE epsilon4 to further modify risk. GAB2 was overexpressed in pathologically vulnerable neurons; the Gab2 protein was detected in neurons, tangle-bearing neurons, and dystrophic neuritis; and interference with GAB2 gene expression increased tau phosphorylation. Our findings suggest that GAB2 modifies LOAD risk in APOE epsilon4 carriers and influences Alzheimer's neuropathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553421      PMCID: PMC2587162          DOI: 10.1016/j.neuron.2007.05.022

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  32 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  BCR mediated signal transduction in immature and mature B cells.

Authors:  Gábor Koncz; Csaba Bodor; Dorottya Kövesdi; Róbert Gáti; Gabriella Sármay
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

3.  Essential role for Gab2 in the allergic response.

Authors:  H Gu; K Saito; L D Klaman; J Shen; T Fleming; Y Wang; J C Pratt; G Lin; B Lim; J P Kinet; B G Neel
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

4.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

Authors:  D A Evans; H H Funkenstein; M S Albert; P A Scherr; N R Cook; M J Chown; L E Hebert; C H Hennekens; J O Taylor
Journal:  JAMA       Date:  1989-11-10       Impact factor: 56.272

5.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease.

Authors:  M Bobinski; M J de Leon; J Wegiel; S Desanti; A Convit; L A Saint Louis; H Rusinek; H M Wisniewski
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Cutting edge: gab2 mediates an inhibitory phosphatidylinositol 3'-kinase pathway in T cell antigen receptor signaling.

Authors:  J C Pratt; V E Igras; H Maeda; S Baksh; E W Gelfand; S J Burakoff; B G Neel; H Gu
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

7.  The absence of Grb2-associated binder 2 (Gab2) does not disrupt NK cell development and functions.

Authors:  Simona Zompi; Hahiua Gu; Francesco Colucci
Journal:  J Leukoc Biol       Date:  2004-07-07       Impact factor: 4.962

8.  PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.

Authors:  Lia Baki; Junichi Shioi; Paul Wen; Zhiping Shao; Alexander Schwarzman; Miguel Gama-Sosa; Rachael Neve; Nikolaos K Robakis
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

9.  CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease.

Authors:  Rena Li; Ron Strohmeyer; Zhe Liang; Lih-Fen Lue; Joseph Rogers
Journal:  Neurobiol Aging       Date:  2004-09       Impact factor: 4.673

10.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Authors:  Keith D Coon; Amanda J Myers; David W Craig; Jennifer A Webster; John V Pearson; Diane Hu Lince; Victoria L Zismann; Thomas G Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Douglas G Walker; Rivka Ravid; Christopher B Heward; Joseph Rogers; Andreas Papassotiropoulos; Eric M Reiman; John Hardy; Dietrich A Stephan
Journal:  J Clin Psychiatry       Date:  2007-04       Impact factor: 4.384

View more
  213 in total

1.  Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population.

Authors:  Quan Yuan; Changbiao Chu; Jianping Jia
Journal:  Neurol Sci       Date:  2011-12-14       Impact factor: 3.307

2.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Jason J Corneveaux; Amanda J Myers; April N Allen; Jeremy J Pruzin; Manuel Ramirez; Anzhelika Engel; Michael A Nalls; Kewei Chen; Wendy Lee; Kendria Chewning; Stephen E Villa; Hunsar B Meechoovet; Jill D Gerber; Danielle Frost; Hollie L Benson; Sean O'Reilly; Lori B Chibnik; Joshua M Shulman; Andrew B Singleton; David W Craig; Kendall R Van Keuren-Jensen; Travis Dunckley; David A Bennett; Philip L De Jager; Christopher Heward; John Hardy; Eric M Reiman; Matthew J Huentelman
Journal:  Hum Mol Genet       Date:  2010-06-09       Impact factor: 6.150

Review 3.  Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.

Authors:  Richard Mayeux; Nicole Schupf
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

4.  Gab2 promotes colony-stimulating factor 1-regulated macrophage expansion via alternate effectors at different stages of development.

Authors:  Angel W Lee; Yingwei Mao; Josef M Penninger; Soojie Yu
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

5.  Evaluating de novo locus-disease discoveries in GWAS using the signal-to-noise ratio.

Authors:  Xia Jiang; M Michael Barmada; Michael J Becich
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

6.  On the meta-analysis of genome-wide association studies: a robust and efficient approach to combine population and family-based studies.

Authors:  Sungho Won; Qing Lu; Lars Bertram; Rudolph E Tanzi; Christoph Lange
Journal:  Hum Hered       Date:  2012-01-18       Impact factor: 0.444

Review 7.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  APOE is not associated with Alzheimer disease: a cautionary tale of genotype imputation.

Authors:  Gary W Beecham; Eden R Martin; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Ann Hum Genet       Date:  2010-05       Impact factor: 1.670

Review 9.  Common neurodegenerative diseases: dissection by genome-wide association.

Authors:  Vincenzo Bonifati
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

10.  No association between CALHM1 and Alzheimer's disease risk.

Authors:  Lars Bertram; Brit-Maren M Schjeide; Basavaraj Hooli; Kristina Mullin; Mikko Hiltunen; Hilkka Soininen; Martin Ingelsson; Lars Lannfelt; Deborah Blacker; Rudolph E Tanzi
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.